Medicare Enrolled

Dr. Amita Patnaik, M.D.

Medical Oncology · San Antonio, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
4383 MEDICAL DR, San Antonio, TX 78229
2105935700
In practice since 2005 (20 years)
NPI: 1538162029 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patnaik from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patnaik? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patnaik

Dr. Amita Patnaik is a medical oncology specialist in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Patnaik performed 1,817 Medicare services across 547 unique beneficiaries.

Between the years covered by Open Payments, Dr. Patnaik received a total of $30,955 from 20 pharmaceutical and/or device companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patnaik is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 48% volume in TX $30,955 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,817
Medicare services
Top 48% in TX for medical oncology
547
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~91 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Magnesium sulfate injection, per 500 mg
An injection of magnesium sulfate administered in 500 mg increments.
228 $1 $2
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
216 $98 $374
Injection, potassium chloride, per 2 meq 190 $0 $0
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
178 $10 $32
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
153 $8 $23
Anti-nausea injection (Aloxi/palonosetron) 130 $1 $25
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
116 $127 $523
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
81 $98 $377
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
78 $49 $185
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
71 $22 $86
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
40 $10 $47
Intravenous hydration infusion, 31-60 minutes
Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes.
39 $25 $137
Normal saline infusion, 500 ml
Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution.
38 $1 $9
Complete blood count (CBC), automated
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood.
37 $6 $19
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
37 $1 $3
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
35 $10 $42
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
34 $16 $60
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
30 $68 $272
Intravenous drug injection
A procedure involving the administration of a medication or substance directly into a vein.
21 $29 $131
Normal saline infusion, 1000 cc
Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution.
21 $2 $19
Prothrombin time test (blood clotting)
A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process.
15 $4 $13
Coagulation assessment blood test
A blood test that measures how long it takes for blood to clot. The sample can be plasma or whole blood.
15 $6 $18
Direct bilirubin level test
A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver.
14 $5 $15
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
19.9% high complexity
35.6% medium
44.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$30,955
Total received (2018-2024)
Avg $4,422/year across 7 years
Top 26% in TX for medical oncology
20
Companies
67
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$22,811 (73.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,588 (18.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,555 (8.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$8,280
2023
$168
2022
$22
2021
$7,171
2020
$37
2019
$14,204
2018
$1,073

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Global Services, LLC
$8,308
PFIZER INC.
$6,333
Seattle Genetics, Inc.
$5,588
Daiichi Sankyo Inc.
$3,783
Gilead Sciences, Inc.
$3,400
Eli Lilly and Company
$1,840
Merck Sharp & Dohme Corporation
$1,044
Genentech USA, Inc.
$162
Celgene Corporation
$137
Merck Sharp & Dohme LLC
$62
Bayer HealthCare Pharmaceuticals Inc.
$46
Lilly USA, LLC
$45
E.R. Squibb & Sons, L.L.C.
$43
Novartis Pharmaceuticals Corporation
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Foundation Medicine, Inc.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$23
PUMA BIOTECHNOLOGY, INC.
$20
EMD Serono, Inc.
$17
Astellas Pharma US Inc
$16
Top 3 companies account for 65.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · Bavencio · CC-122 · CYRAMZA · Enhertu · FOUNDATIONONE · GAZYVA · GILOTRIF · KEYTRUDA · Kadcyla · LORBRENA · OPDIVO · OPDUALAG · PROMACTA · Perjeta · Pomalyst · REBLOZYL · RYDAPT · Stivarga · VERZENIO · Xospata
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (74%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $1,704 per 100 Medicare services performed
Looking for a medical oncology specialist in San Antonio?
Compare medical oncologists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
37
Per 100K population
1.8
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Patnaik is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Patnaik experienced with magnesium sulfate injection, per 500 mg?
Based on Medicare claims data, Dr. Patnaik performed 228 magnesium sulfate injection, per 500 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patnaik receive payments from pharmaceutical companies?
Yes. Dr. Patnaik received a total of $30,955 from 20 companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patnaik's costs compare to other medical oncologists in San Antonio?
Dr. Patnaik's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patnaik) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →